When a Gibson, Dunn & Crutcher team defended Sanofi-Aventis SA against novel accusations that it defrauded the government by improperly getting a drug patent, it had to master a lot of sophisticated scientific concepts. But in the end, the case boiled down to something more digestible: the credibility of one of their opponent’s main witnesses on the stand.
“In every lawsuit—no matter how complicated it is—the issue can oftentimes be stated very simply,” said Gibson Dunn ‘s William Dawson, who led Sanofi’s legal team.
